Comments
Vertex posts loss as hepatitis drug sales plunge
02.11.2012. | (Reuters) - Vertex Pharmaceuticals Inc reported a net loss for the third quarter on Thursday with results hurt by fast-declining sales of its Incivek hepatitis C drug, as the company turned its attention to developing a next generation of treatments for the serious liver disease....
